Overexpression of RUVBL1, RUVBL2, ILF2, ILF3, and HNRNPM are observed in various cancers with their progression (RUVBL1 and RUVBL222,46, ILF2 and ILF347–49, HNRNPM50,51). The gene discussed is ILF3; the disease is cancer.